GB201308738D0 - Novel polymer conjugates - Google Patents

Novel polymer conjugates

Info

Publication number
GB201308738D0
GB201308738D0 GBGB1308738.2A GB201308738A GB201308738D0 GB 201308738 D0 GB201308738 D0 GB 201308738D0 GB 201308738 A GB201308738 A GB 201308738A GB 201308738 D0 GB201308738 D0 GB 201308738D0
Authority
GB
United Kingdom
Prior art keywords
polymer conjugates
novel polymer
novel
conjugates
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1308738.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abzena UK Ltd
Original Assignee
Polytherics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polytherics Ltd filed Critical Polytherics Ltd
Priority to GBGB1308738.2A priority Critical patent/GB201308738D0/en
Publication of GB201308738D0 publication Critical patent/GB201308738D0/en
Priority to PCT/GB2014/051493 priority patent/WO2014184564A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
GBGB1308738.2A 2013-05-15 2013-05-15 Novel polymer conjugates Ceased GB201308738D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1308738.2A GB201308738D0 (en) 2013-05-15 2013-05-15 Novel polymer conjugates
PCT/GB2014/051493 WO2014184564A1 (en) 2013-05-15 2014-05-15 Novel polymer conjugates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1308738.2A GB201308738D0 (en) 2013-05-15 2013-05-15 Novel polymer conjugates

Publications (1)

Publication Number Publication Date
GB201308738D0 true GB201308738D0 (en) 2013-06-26

Family

ID=48700826

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1308738.2A Ceased GB201308738D0 (en) 2013-05-15 2013-05-15 Novel polymer conjugates

Country Status (2)

Country Link
GB (1) GB201308738D0 (en)
WO (1) WO2014184564A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016059377A1 (en) 2014-10-14 2016-04-21 Polytherics Limited Process for the conjugation of a peptide or protein with a reagent comprising a leaving group including a portion of peg
US10098960B2 (en) 2015-04-03 2018-10-16 Ucl Business Plc Polymer conjugate
EP3941933A4 (en) * 2019-03-20 2023-07-26 Kindred Biosciences, Inc. Ngf antagonists for medical use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0122400D0 (en) * 2001-09-17 2001-11-07 Univ Bristol Polypeptide purification method
GB0316294D0 (en) * 2003-07-11 2003-08-13 Polytherics Ltd Conjugated biological molecules and their preparation
US9005598B2 (en) * 2009-03-04 2015-04-14 Polytherics Limited Conjugated proteins and peptides

Also Published As

Publication number Publication date
WO2014184564A1 (en) 2014-11-20

Similar Documents

Publication Publication Date Title
HUS2300020I1 (en) Pyrrolobenzodiazepine-antibody conjugates
IL244816B (en) Protein-polymer-drug conjugates
IL245009A0 (en) Protein-polymer-drug conjugates
EP2970511A4 (en) Insulin-incretin conjugates
GB201600779D0 (en) Conjugated polymers
ZA201502523B (en) Pyrrolobenzodiazepine-anitbody conjugates
EP2975043A4 (en) Olefin-based polymer
PL2984138T3 (en) Polymer compound
HK1216155A1 (en) Jellyfish-derived polymer
SG11201605260VA (en) Var2csa-drug conjugates
EP2970645A4 (en) Hinge polymer
IL245099A0 (en) Polymeric radiation-sources
EP3003326A4 (en) Polymer chelator conjugates
EP2968381A4 (en) Sugar-linker-drug conjugates
EP2956141A4 (en) Novel uses
TWI561543B (en) Multy-block copolymer
ZA201603260B (en) Functionalized polymer composition
ZA201508390B (en) Anti-bacterial siderophore-aminopenicillin conjugates
PL3041513T3 (en) Factor viii zwitterionic polymer conjugates
GB201308738D0 (en) Novel polymer conjugates
EP2836238A4 (en) Co-polymer conjugates
GB201309805D0 (en) New polymer
GB201309919D0 (en) TC-Met-N-BG polymer edditive
GB201317842D0 (en) Improved polymer preparation
GB201307707D0 (en) Improved polymer preparation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)